Doctor Krishnaraj Sinhji Rathod
Barts Heart Centre, London (United Kingdom of Great Britain & Northern Ireland)
Membership:
FESC Member
Biography
Krishnaraj Rathod MBBS BMedSci(Hons) MRCP FHEA FESC completed medicine at Barts School of Medicine with two distinctions and an intercalated degree in Molecular Therapeutics (1st Class Hons). He is currently an Interventional Cardiology Consultant at Barts Heart Centre and Senior Clinical Lecturer at Queen Mary University of London. His PhD was funded by a highly prestigious NIHR Doctoral Research Fellowship based on the investigation of the effect of dietary nitrate in patients with stable angina. He has published over 100 papers and 200 abstracts.
His primary research interests are based around translational interventional clinical trials, including a phase II & III clinical trials. He is currently completing an MSc in clinical trials. Other interests include the cost-effectiveness of therapies in cardiovascular disease, the treatment of reperfusion injury following myocardial infarction and observational studies of long outcomes following percutaneous coronary intervention.
Contributor content
Presentation
The association between prior coronary artery bypass graft surgery and outcome after percutaneous coronary intervention (PCI): an observational study of 123,780 patients
Presentation
Inter-hospital transfer for primary PCI has worse outcome compared with direct admission to a heart attack centre: an study of 25,315 patients with STEMI from the London Heart Attack Group
Presentation
The association between prior coronary artery bypass graft surgery and outcome after percutaneous coronary intervention (PCI): a study from the Pan-London PCI (BCIS) Registry
Presentation
Inter-hospital transfer for primary PCI has worse outcome compared with direct admission to a heart attack centre: observational study of 25,315 patients with STEMI from the London heart attack group
Presentation
Patients with prior CABG treated with primary PCI have high long-term adverse outcome: an observational study of 26,799 patients with STEMI from the London heart attack group
Presentation
